Author(s):
Sulabha Sambhaji Lalsare
Email(s):
sulabhalalsare@gmail.com
DOI:
10.52711/0974-360X.2024.00855 
Address:
Sulabha Sambhaji Lalsare
Associate Professor, SSSM Arts, Science and Commerce College, Saikheda, Niphad, Nashik, 422210, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 11,
Year - 2024
ABSTRACT:
Pharmaceutical aerosols are frequently used in respiratory drug delivery for the treatment of various pulmonary conditions. A nebulizer device transforms fluid drug into an awfully fine mist that an individual inhalevia mask or mouthpiece. Administering medication in this manner allows it to be directed straight into the lungs and facilitated to the desired site. Traditional pMDIs and DPIs have long been preferred but come with lots of performance issues and patient factors. However, newer nebulization advancementsdeveloped in the last several decades, various nebulizers can now be used for portable use outside of the home, where local medicine administration to the lungs lowers dosage requirements and adverse effects as compared to alternative delivery methods. The primary objective behind the current article is to review the performance of various nebulizers prescribed in the market and their impact on patient safety. The current review deals with the generations of nebulizer devices present in the market along with their significances. The review also covers the mechanism with which these nebulizers operate, and the most important is a difference in the nebulization time of different nebulizers, which directly affects the drug delivery to the site of action.This review covers how important it is to use recommended nebulizers as a difference in nebulization time by using non-recommended nebulizer can lead to hyper or hypo delivery of doses to the site of action, thus leading to resistance and is likely to compromise the safety of patients.
Cite this article:
Sulabha Sambhaji Lalsare. Comparative Evaluation of Nebulizer Devices Present in Market and Factors Influencing Nebulizer Performance. Research Journal of Pharmacy and Technology. 2024; 17(11):5605-5. doi: 10.52711/0974-360X.2024.00855
Cite(Electronic):
Sulabha Sambhaji Lalsare. Comparative Evaluation of Nebulizer Devices Present in Market and Factors Influencing Nebulizer Performance. Research Journal of Pharmacy and Technology. 2024; 17(11):5605-5. doi: 10.52711/0974-360X.2024.00855 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-11-63
13. REFERENCES:
1. Reychler G, Leal T, Roeseler J, Thys F, Delvau N, Liistro G. Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin. Respiratory Medicine. 2007; Oct 1; 101(10): 2051-5.
2. Respaud R, Vecellio L, Diot P, Heuzé-Vourc’h N. Nebulization as a delivery method for mAbs in respiratory diseases. Expert Opinion on Drug Delivery. 2015; 12(6): 1027-39.
3. Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. The Lancet. 2011; 377(9770): 1032-45.
4. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2002;19(4-5).
5. Hapse SA, Tarkase KN, Jadhav AS, Dongare US. Study and evaluation of dry powder inhaler-a review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(3): 87-92.
6. Carvalho TC, McConville JT. The function and performance of aqueous aerosol devices for inhalation therapy. Journal of Pharmacy and Pharmacology. 2016; 68(5): 556-78.
7. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. British journal of clinical pharmacology. 2003; 56(6): 600-12.
8. Kaur R, Sharma JN. Deflection in Micro-Scale Thermoelastic simply-supported beams due to patch loading. Research Journal of Science and Technology. 2013; 5(1): 153-9.
9. Mukherjee B, Paul P, Dutta L, Chakraborty S, Dhara M, Mondal L, Sengupta S. Pulmonary Administration of Biodegradable Drug Nanocarriers for More Efficacious Treatment of Fungal Infections in Lungs: Insights Based on Recent Findings. InMultifunctional Systems for Combined Delivery, Biosensing and Diagnostics. 2017: 261-280.
10. Le Brun PP, De Boer AH, Frijlink HW, Heijerman HG. A review of the technical aspects of drug nebulization. Pharmacy World and Science. 2000; 22(3): 75-81.
11. Patton JS, Brain JD, Davies LA, Fiegel J, Gumbleton M, Kim KJ, Sakagami M, Vanbever R, Ehrhardt C. The particle has landed—characterizing the fate of inhaled pharmaceuticals. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2010; Dec 1; 23(S2): S-71.
12. Nadig S, Rajeshwari R. Effectiveness of structured teaching programme on knowledge and techniques regarding metered dose inhalers (MDI) among bronchial asthma patients in selected hospitals of Mangalore taluk. International Journal of Advances in Nursing Management. 2016; 4(3): 223-34.
13. More S, Mirza J, Kale N, Gandhi M, Chaudhari R. Formulation and Development of a “Pressurised Metered Dose Inhalation” beclomethasone 250 mcg. Research Journal of Pharmacy and Technology. 2014; 7(9): 963-7.
14. Maurya PR, Joshi YM, Kadam VJ. A Review on Bronchial asthma. Research Journal of Pharmacology and Pharmacodynamics. 2013; Nov 21; 5(4): 257-65.
15. Ehrmann S, Chastre J, Diot P, Lu Q. Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care. Annals of Intensive Care. 2017; Dec 1; 7(1): 78.
16. Farncombe M, Chater S. Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease. Supportive Care in Cancer. 1994; 2(3): 184-7.
17. Sen A, Kumar K, Khan S, Pathak P, Singh A. Current therapy in cancer: advances, challenges, and future directions. Asian Journal of Nursing Education and Research. 2024; 14(1): 77-4.
18. Yeo LY, Friend JR, McIntosh MP, Meeusen EN, Morton DA. Ultrasonic nebulization platforms for pulmonary drug delivery. Expert opinion on drug delivery. 2010; 7(6): 663-79.
19. Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. International Journal of Pharmaceutics. 2010; 392(1-2): 1-9.
20. Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Medical Devices (Auckland, NZ). 2015; 8: 131.
21. Bono M, Ruff G, inventors; Bono, Michael, Ruff, Gary, assignee. Nebulizer and inhalation device containing same. United States Patent US 5,630,409. 1997 May 20.
22. Clark AR. Medical aerosol inhalers: past, present, and future. Aerosol Science and Technology. 1995; 22(4): 374-91.
23. Dalby R, Suman J. Inhalation therapy: technological milestones in asthma treatment. Advanced Drug Delivery Reviews. 2003; 55(7): 779-91.
24. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respiratory care. 2004; Feb 1; 49(2): 174-9.
25. Verdun AM, Blacker R, inventors; 1263152 Ontario Inc, assignee. Breath actuated nebulizer with valve assembly having a relief piston. United States Patent US 6,044,841. 2000 Apr 4.
26. Ramya A, Geetha P, Nandhini M, Raja M. The role of leukotriene receptor antagonist as an add on therapy to β2-Agonists in acute asthma. Research Journal of Pharmacy and Technology. 2019; Aug 8; 12(4): 1974-8.
27. Jayeshkumar SM, Yashvi P, Bhimani B, Patel G, Patel J, Patel U. Nebulization therapy for lung cancer. Research Journal of Pharmacy and Technology. 2019; 12(2): 920-34.
28. Dhand R. Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.
29. Harvey CJ, O'Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. European Respiratory Journal. 1997; 10(4): 905-9.
30. Pritchard JN, Hatley RH, Denyer J, Hollen DV. Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments. Therapeutic Delivery. 2018; 9(2): 121-36.
31. Elphick M, von Hollen D, Pritchard JN, Nikander K, Hardaker LE, Hatley RH. Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opinion on Drug Delivery. 2015; 12(8): 1375-87.
32. Chandel A, Goyal AK, Ghosh G, Rath G. Recent advances in aerosolised drug delivery. Biomedicine and Pharmacotherapy. 2019; Apr 1; 112: 108601.
33. Rau JL. The inhalation of drugs: advantages and problems. Respiratory care. 2005; Mar 1; 50(3): 367-82.
34. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respiratory Care. 2005; Oct 1; 50(10): 1360-75.
35. Branch PS. Best Practice Guidelines for the Cleaning, Disinfection and Sterilization of Medical Devices in Health Authorities.
36. Murthy GL, Machale MU, Balireddy N, Chandrika C. Outlines of aerosols in pharmaceutical technology. Asian Journal of Research in Pharmaceutical Science. 2019; 9(3): 215-25.
37. Lipworth BJ, Clark DJ. Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax. 1997; Dec 1; 52(12): 1036-9.
38. Boe J, Dennis JH, O'driscoll BR, Bauer TT, Carone M, Dautzenberg B, Diot P, Heslop K, Lannefors L. European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers. European Respiratory Journal. 2001; Jul 1; 18(1): 228-42.
39. Dailey LA, Schmehl T, Gessler T, Wittmar M, Grimminger F, Seeger W, Kissel T. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. Journal of Controlled Release. 2003; Jan 9; 86(1): 131-44.
40. Steckel H, Eskandar F. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. European Journal of Pharmaceutical Sciences. 2003; Aug 1; 19(5): 443-55.
41. Berg E, Svensson JO, Asking L. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration. Journal of Aerosol Medicine. 2007; Jun 1; 20(2): 97-104.
42. Laube BL, Benedict GW, Dobs AS. Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus. Journal of Aerosol Medicine. 1998; 11(3): 153-73.
43. Knoch M, Finlay W. Nebulizer technologies. Drugs and The Pharmaceutical Sciences. 2003; 126: 849-56.
44. Martin AR, Finlay WH. nebulizers for drug delivery to the lungs. Expert Opinion on Drug Delivery. 2015; Jun 3; 12(6): 889-900.
45. Pleasants RA, Hess DR. Aerosol delivery devices for obstructive lung diseases. Respiratory Care. 2018; Jun 1; 63(6): 708-33.
46. Alshlowi MO. The Impact of Aerosol Devices and Delivery Interfaces on Aerosol Deposition in Children Receiving Noninvasive Ventilation.
47. Siavash M, Rahrovi A, Olamazadeh S, Esmaili M. Production and Clinical Application of the First Iranian Ultrasonic Desktop Nebulizer. Advanced Biomedical Research. 2018; 7(1): 114.
48. Faurisson F, Dessanges JF, Grimfeld A, Beaulieu R, Kitzis MD, Peytavin G, Lefebvre JP, Farinotti R, Sautegeau A. Nebulizer performance: AFLM study. Respiration. 1995; 62(Suppl. 1): 13-8.
49. Kacmarek RM, Stoller JK, Heuer A. Egan's Fundamentals of Respiratory Care E-Book. Elsevier Health Sciences; 2019; Dec 18.
50. Rau JL. Design principles of liquid nebulization devices currently in use. Respiratory Care. 2002; Nov; 47(11): 1257.
51. Mittal G, Kumar N, Rawat H, Chopra MK, Bhatnagar A. A radiometric study of factors affecting drug output of jet nebulizers. Indian Journal of Pharmaceutical Sciences. 2010; Jan; 72(1): 31.
52. Zanaty OM, El Metainy SA. A comparative evaluation of nebulized dexmedetomidine, nebulized ketamine, and their combination as premedication for outpatient pediatric dental surgery. Anesthesia and Analgesia. 2015; Jul 1; 121(1): 167-71.
53. Hickle RS, inventor; Scott Laboratories Inc, assignee. Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures. United States patent US 6,745,764. 2004 Jun 8.
54. Sampoornam W. Research patent. Asian Journal of Nursing Education and Research. 2012; Apr 1; 2(2): 73.
55. Pipkin JD, Zimmerer RO, Thompson DO, Mosher GL, inventors; CydexInc, assignee. Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid. United States Patent US 10,207, 008. 2019 Feb 19.
56. Germinario LT, Hebrank JH, Hunter CE, Stern TP, inventors; Pneuma Respiratory Inc, assignee. Methods for treatment of pulmonary lung diseases with improved therapeutic efficacy and improved dose efficiency. United States Patent Application US 16/098,800. 2019 May 2.
57. Ballini F, inventor; MefarSpA, assignee. Micronized douche device for cleasing nasal and neighboring cavities. United States patent US 5,649,530. 1997 Jul 22.
58. Djupesland PG, inventor; OptiNose AS, assignee. Nasal administration. United States patent application US 14/780,277. 2016 Feb 18.
59. Djupesland PG, Mahmoud RA, Messina J, inventors; OptiNose AS, assignee. Nasal administration. United States Patent application US 14/315,132. 2015 May 28.
60. Cortez FV, Niland WF, Boyd P, McGarrity G, Buyer C, inventors; VapothermInc, assignee. Heated nebulizer devices, nebulizer systems, and methods for inhalation therapy. United States Patent US 8,561,607. 2013 Oct 22.
61. Hickle RS, inventor; Scott Laboratories Inc, assignee. Drug delivery in association with medical or surgical procedures. United States Patent US 8,882,703. 2014 Nov 11.
62. Emerson JH, inventor. Aspirator for administering medicine. United States patent US 2,535,844. 1950 Dec 26.
63. Bologna WJ, inventor; Columbia Laboratories Inc, assignee. Dispensing vial for feminine hygiene products. United States Patent Application US 29/019,916. 1996 Nov 5.
64. Ivri Y, Wu CH, inventors; AerogenInc, assignee. Liquid dispensing apparatus and methods. United States Patent US 6,640,804. 2003 Nov 4.